ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Gaudium IVF And Women Health Earnings Call: Key Takeaways

Gaudium IVF reported strong FY26 performance with consolidated revenue at ₹10,435.70 Lakhs and PAT of ₹2,448.85 Lakhs, driven by its recent IPO and AI-led clinical excellence.

Why this was an Alfa AlertNot a filter event. Results show growth but no explicit beat of management-stated guidance ranges provided in the deck.
Highlights
Revenue growth47.56% YoY consolidated growth in FY26.
MarginsConsolidated EBITDA margin at 36.13%; Standalone at 48.29%.
Demand visibilityStrong; driven by declining fertility rates and delayed parenthood.
Management confidenceHigh; citing category leadership and successful IPO listing.

Growth

FY26 Consolidated Revenue grew 47.56% YoY; PAT grew 27.69% YoY. Standalone core IVF revenue rose 21.32% to ₹7,157.85 Lakhs.

Outlook

Aggressive expansion planned: 10 new hubs in FY27 (Delhi/Nagpur), 8 centers in FY28, and 1 in FY29.

Risks

Margins slightly contracted (PAT margin 27% to 23.5%) due to expansion and IPO-related capital changes.

Source

Earnings Call filed with NSE, NSE: GAUDIUMIVF. Summary written with AI assistance from the document.

Read the document ↗

Gaudium IVF And Women Health Ltd: key numbers

Share price
₹110.29
Market cap
₹802.8 Cr
Revenue (annual)
₹104.4 Cr
Net profit (annual)
₹24.46 Cr
P/E (TTM)
34.7×Sector 46.8×
Promoter holding
71.29%+0.00% QoQ
FII holding
1.19%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gaudium IVF And Women Health Ltd

All →